Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing

Journal of Bone and Mineral Research

Volumn 24, Issue 6, 2009, Pages 1043-1054

  Taylor, Douglas K ^a,b   Meganck, Jeffrey A ^a,c   Terkhorn, Shawn ^d   Rajani, Rajiv ^c   Naik, Amish ^e   O'Keefe, Regis J ^e   Goldstein, Steven A ^a,c   Hankenson, Kurt D ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CT; Fracture; Thrombospondin

Indexed keywords

COLLAGEN TYPE 2; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR; OSTEOCALCIN; THROMBOSPONDIN 2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN;

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE REGENERATION; CALLUS; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; FRACTURE HEALING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MECHANICAL TORSION; MESENCHYME CELL; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BONE DENSITY; CARTILAGE; DNA PRIMERS; FRACTURE HEALING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; THROMBOSPONDINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66349123284     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090101     Document Type: Article

References (48)

1. Einhorn TA 1998 The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355(Suppl):S7-S21.
2. Li G, White G, Connolly C, Marsh D 2002 Cell proliferation and apoptosis during fracture healing. J Bone Miner Res 17:791-799.
3. Ford JL, Robinson DE, Scammell BE 2003 The fate of soft callus chondrocytes during long bone fracture repair. J Orthop Res 21:54-61.
4. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA 2003 Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873-884.
5. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
6. Glowacki J 1998 Angiogenesis in fracture repair. Clin Orthop Relat Res 355(Suppl):S82-S89.
7. Pacicca DM, Patel N, Lee C, Salisbury K, Lehmann W, Carvalho R, Gerstenfeld LC, Einhorn TA 2003 Expression of angiogenic factors during distraction osteogenesis. Bone 33:889-898.
8. Colnot CI, Helms JA 1902 A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 100:245-250.
9. Fujimoto T, Kitazawa R, Maeda S, Mizuno K, Kitazawa S 2001 BMP-3 mRNA expression during endochondral ossification of mouse bone tissue. Acta Histochem Cytochem 34:1-7.
10. Maes C, Coenegrachts L, Stockmans I, Daci E, Luttun A, Petryk A, Gopalakrishnan R, Moermans K, Smets N, Verfaillie CM, Carmeliet P, Bouillon R, Carmeliet G 2006 Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116:1230-1242.
11. Ekholm E, Hankenson KD, Uusitalo H, Hiltunen A, Gardner H, Heino J, Penttinen R 2002 Diminished callus size and cartilage synthesis in alphalbetal integrin-deficient mice during bone fracture healing. Am J Pathol 160:1779-1785.
12. Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE 2007 Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 22:286-297.
13. Adams JC, Lawler J 2004 The thrombospondins. Int J Biochem Cell Biol 36:961-968.
14. Bornstein P, O'Rourke K, Wikstrom K, Wolf FW, Katz R, Li P, Dixit VM 1991 A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem 266:12821-12824.
15. Bornstein P 2001 Thrombospondins as matricellular modulators of cell function. J Clin Invest 107:929-934.
16. Hankenson KD, Bain SD, Kyriakides TR, Smith EA, Goldstein SA, Bornstein P 2000 Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15:851-862.
17. Hankenson KD, Ausk BJ, Bain SD, Bornstein P, Gross TS, Srinivasan S 2006 Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading. Bone 38:310-316.
18. Kyriakides TR, Bornstein P 1999 Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 113:782-787.
19. Krady MM, Zeng J, Yu J, Maclauchlan S, Skokos EA, Tian W, Bornstein P, Sessa WC, Kyriakides TR 2008 Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis. Am J Pathol. 173:879-891.
20. Armstrong LC, Bjorkblom B, Hankenson KD, Siadak AW, Stiles CE, Bornstein P 2002 Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol Biol Cell 13:1893-1905.
21. Oganesian A, Armstrong LC, Migliorini MM, Strickland DK, Bornstein P 2008 Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 19:563-571.
22. Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J, Detmar M 1999 Overexpression of thrombospondin- 1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155:441-452.
23. Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange- Asschenfeldt B, Brown LF, Vacanti JP, Detmar M 2002 Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res 62:2004-2012.
24. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P 1998 Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419-430.
25. Hiltunen A, Vuorio E, Aro HT 1993 A standardized experimental fracture in the mouse tibia. J Orthop Res 11:305-312.
26. Den Boer FC, Bramer JA, Patka P, Bakker FC, Barentsen RH, Feilzer AJ, de Lange ES, Haarman HJ 1998 Quantification of fracture healing with three-dimensional computed tomography. Arch Orthop Trauma Surg 117:345-350.
27. Kyriakides TR, Rojnuckarin P, Reidy MA, Hankenson KD, Papayannopoulou T, Kaushansky K, Bornstein P 2003 Meg- akaryocytes require thrombospondin-2 for normal platelet formation and function. Blood 101:3915-3923.
28. Hankenson KD, Bornstein P 2002 The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res 17:415-425.
29. Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z 2000 Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19:557-568.
30. Uusitalo H, Hiltunen A, Ahonen M, Gao TJ, Lefebvre V, Harley V, Kahari VM, Vuorio E 2001 Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J Bone Miner Res 16:1837-1845.
31. Sakano S, Murata Y, Miura T, Iwata H, Sato K, Matsui N, Seo H 1993 Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop Relat Res 337-344.
32. Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, Koopman P, Clemens TL 2005 Hypoxia induces chondrocyte- specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37:313-322.
33. Gleadle JM, Ratcliffe PJ 1997 Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase. Blood 89:503-509.
34. Schipani E 2005 Hypoxia and HIF-1 alpha in chondrogenesis. Semin Cell Dev Biol 16:539-546.
35. Provot S, Zinyk D, Gunes Y, Kathri R, Le Q, Kronenberg HM, Johnson RS, Longaker MT, Giaccia AJ, Schipani E 2007 Hif- 1{alpha} regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 177:451-464.
36. Taraboletti G, Roberts D, Liotta LA, Giavazzi R 1990 Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J Cell Biol 111:765-772.
37. Carpizo D, Iruela-Arispe ML 2000 Endogenous regulators of angiogenesis-emphasis on proteins with thrombospondin-type I motifs. Cancer Metastasis Rev 19:159-165.
38. Lawler J 2000 The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 12:634-640.
39. Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar M 1999 Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 96:14888-14893.
40. Jimenez B, Volpert OV, Reiher F, Chang L, Munoz A, Karin M, Bouck N 2001 c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene 20:3443-3448.
41. Hausman MR, Schaffler MB, Majeska RJ 2001 Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29:560-564.
42. Tarkka T, Sipola A, Jamsa T, Soini Y, Yla-Herttuala S, Tuukkanen J, Hautala T 2003 Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5:560-566.
43. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS 2001 Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15:2865-2876.
44. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E 2007 HIF1{alpha} regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134:3917-3928.
45. Irwin R, LaPress JJ, Kinser S, McCabe LR 2007 Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype. J Cell Biochem 100:762-772.
46. Dailey L, Laplantine E, Priore R, Basilico C 2003 A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161:1053-1066.
47. Moro T, Ogasawara T, Chikuda H, Ikeda T, Ogata N, Maruyama Z, Komori T, Hoshi K, Chung UI, Nakamura K, Okayama H, Kawaguchi H 2005 Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5. J Cell Physiol 204:927-933.
48. Wang G, Beier F 2005 Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis. J Bone Miner Res 20:1022-1031.